XML 96 R51.htm IDEA: XBRL DOCUMENT v3.2.0.727
Earnings per Share (Details Textuals) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended
Dec. 01, 2014
Dec. 02, 2013
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Nov. 08, 2014
Sep. 30, 2014
Nov. 07, 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Impact of convertible notes     1,500,000 1,800,000 1,300,000 0      
Impact of restricted shares, restricted share units and performance share units     1,800,000 1,600,000 2,000,000 1,500,000      
Share-based compensation expense     $ 3 $ 2 $ 8 $ 6      
Executive Officer | Performance Shares                  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Number or shares issuable per performance share unit             1   1
Exercise price $ 13.74 $ 7.97              
Performance period       3 years 3 years        
Shares authorized for grant     600,000   600,000     1,800,000  
Impact of convertible notes     900,000   800,000        
Executive Officer | Performance Shares | Minimum                  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Performance-based vesting percentage       0.00% 0.00%        
Executive Officer | Performance Shares | Maximum                  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Performance-based vesting percentage       200.00% 200.00%        
Executive Officer | Performance Shares | Performance Objective One                  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Award vesting rights percentage       50.00% 75.00%        
Executive Officer | Performance Shares | Performance Objective Two                  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Award vesting rights percentage       25.00% 25.00%        
Executive Officer | Performance Shares | Performance Objective Three                  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Award vesting rights percentage       25.00%          
Executive Officer | Restricted Share Units (RSUs)                  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Exercise price $ 13.74                
Shares granted 400,000                
Vesting period 3 years                
Stock Options, Out-of-the-Money                  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Antidilutive shares excluded from computation of earnings per share       100,000   400,000      
7.875% Convertible Notes Due 2026 | Convertible Notes Payable                  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]                  
Interest rate     7.875%   7.875%     7.875%